ArticlePharmaceuticals (Basel, Switzerland)2025

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.

David Cabezas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.